Abstract:Background: Currently, no satisfactory biomarkers are available to screen for lung cancer. Surface-Enhanced Laser Desorption/ionization Time-of- Flight Mass Spectrometry ProteinChip system (SELDI-TOF-MS) is one of the currently used techniques to identify biomarkers for cancers. The aim of this study is to explore the application of serum SELDI proteomic patterns to distinguish lung cancer patients from healthy individuals.Methods: A total of 208 serum samples, including 158 lung cancer patients and 50 healthy individuals, were randomly divided into a training set (including 11 sera from patients with stages I/II lung cancer, 63 from patients with stages III/IV lung cancer and 20 from healthy controls) and a blinded test set (including 43 sera from patients with stages I/II lung cancer, 41 from patients with stages III/IV lung cancer and 30 from healthy controls). All samples were analyzed by SELDI technology. The spectra were generated on weak cation exchange (WCX2) chips, and protein peaks clustering and classification analyses were made using Ciphergen Biomarker Wizard and Biomarker Pattern software, respectively. We additionally determined Cyfra21-1 and NSE in the 208 serum samples included in this study using an electrochemiluminescent immunoassay.Results: Five protein peaks at 11493, 6429, 8245, 5335 and 2538 Da were automatically chosen as a biomarker pattern in the training set. When the SELDI marker pattern was tested with the blinded test set, it yielded a sensitivity of 86.9%, a specificity of 80.0% and a positive predictive value of 92.4%. The sensitivities provided by Cyfra21-1 and NSE used individually or in combination were significantly lower than that of the SELDI marker pattern (P < 0.005 or 0.05, respectively). Based on the results of the test set, we found that the SELDI marker pattern showed a sensitivity of 91.4% in the detection of non-small cell lung cancers (NSCLC), which was significantly higher than that in the detection of small cell lung cancers (P < 0.05); The pattern also had a sensitivity of 79.1% in the detection of lung cancers in stages I/II.Conclusion: These results suggest that serum SELDI protein profiling can distinguish lung cancer patients, especially NSCLC patients, from normal subjects with relatively high sensitivity and specificity, and the SELDI- TOF- MS is a potential tool for the screening of lung cancer.

Application of Seldi-Tof-Ms Coupled with an Artificial Neural Network Model to the Diagnosis of Pancreatic Cancer

[Application of Saliva Protein Fingerprints in the Diagnosis of Oral Squamous Cell Cancer by Surface Enhanced Laser Desorption Ionization Time of Flight Mass].

Diagnosis of pancreatic adenocarcinoma using protein chip technology.

[Establishment of serum protein pattern model for screening pancreatic cancers by SELDI-TOF-MS technique]

[Serum Diagnosis of Head and Neck Squamous Cell Carcinoma Using Surface-Enhanced Desorption Ionization Mass Spectrometry and Artificial Neural Network Analyses].

Prediction Of Pancreatic Cancer By Serum Biomarkers Using Surface-Enhanced Laser Desorption/Ionization-Based Decision Tree Classifi Cation

Diagnostic Application of Serum Protein Pattern and Artificial Neural Network Software in Breast Cancer

Artificial Neural Networks Analysis Of Surface-Enhanced Laser Desorption/Ionization Mass Spectra Of Serum Protein Pattern Distinguishes Colorectal Cancer From Healthy Population

Evaluation of the Effectiveness of a Chemoprevention Model of Pancreatic Adenocarcinoma Using Protein Chip Technology.

Screening for Protein Markers from Serum of Patients with Pancreatic Carcinoma by Protein Finger Printing Technique

Application of Serum Seldi Proteomic Patterns in Diagnosis of Lung Cancer

SELDI-TOF MS profiling of serum for detection of nasopharyngeal carcinoma

Construction of protein profiling models for diagnosis of pancreatic carcinoma

Application of Serum Surface-Enhanced Laser Desorption/ionization Proteomic Patterns in Distinguishing Lung Cancer Patients from Healthy People.

[Using ANN and Serum Protein Pattern Models in Liver Cancer Diagnosis].

SELDI-TOF-MS: the proteomics and bioinformatics approaches in the diagnosis of breast cancer.

[A Predictive Model for Pancreatic Cancer Using Serum Protein Footprint Map].

Artificial Intelligence Algorithm-Based Computerized Tomography Image Features Combined with Serum Tumor Markers for Diagnosis of Pancreatic Cancer

Screening of Serum Biomarkers in Hepatocellular Carcinoma by SELDI Technique: a Preliminary Study

An Integrated Approach to the Detection of Colorectal Cancer Utilizing Proteomics and Bioinformatics

Proposing new early detection indicators for pancreatic cancer: Combining machine learning and neural networks for serum miRNAbased diagnostic model